HCAT · ISSUER CIK 1636422
Health Catalyst, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Health Catalyst, Inc. insiders reported $105K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Kohl Simeon (Chief Executive Officer, Director), with $105K.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$105KInsider buying
$0.00Insider selling
+$105KNet open-market
Oct 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:00 | Oct 1, 2026 | HCAT | Director | A · Grant | — | +128,851 | 128,851 | New | — | ||
| Sep 16, 202616:52 | Sep 14, 2026 | HCAT | Chief Executive Officer, Director | P · Buy | $1.79 | +59,000 | 2,856,385 | +2% | +$105K | -25.2% | +0.2% |
| Sep 16, 202616:52 | Sep 14, 2026 | HCAT | Chief Executive Officer, Director | A · Grant | — | +2,747,385 | 2,797,385 | +5495% | — | ||
| Sep 11, 202616:08 | Sep 10, 2026 | HCAT | CEO, Director | F · Tax | $1.67 | −35,244 | 1,388,406 | -2% | $59K | ||
| Sep 3, 202617:15 | Sep 1, 2026 | HCAT | Director | A · Grant | — | +9,766 | 185,101 | +6% | — | ||
| Sep 3, 202617:11 | Sep 1, 2026 | HCAT | Chief Financial Officer | F · Tax | $1.70 | −17,973 | 704,867 | -2% | $31K | ||
| Sep 3, 202617:10 | Sep 1, 2026 | HCAT | CEO, Director | F · Tax | $1.70 | −321 | 1,423,650 | -0% | $546.86 | ||
| Sep 3, 202616:05 | Sep 1, 2026 | HCAT | General Counsel | F · Tax | $1.70 | −13,167 | 351,372 | -4% | $22K |